© 2002 by European Society of Cardiology
Copyright © 2002, European Society of Cardiology
Effect of dietary supplementation with 
-3 fatty acids on progression of atherosclerosis in carotid arteries
Klinikum der Universität München, Institut und Poliklinik für Arbeits- und Umweltmedizin–Innenstadt, Ziemssenstrasse 1, D-80336 München, Germany
* Corresponding author. Tel.: +49-89-5160-2440; fax: +49-89-5160-4444 peter.angerer{at}arbeits.med.uni-muenchen.de
Objective: Omega-3 polyunsaturated fatty acids (
-3 PUFA) from fish oil slow atherosclerosis progression in coronary arteries, as we showed in a randomized double-blind placebo-controlled clinical trial. Embedded in this trial, the present study examined the influence of 2 years of dietary supplementation with 1.65 g -3 PUFA per day on progression of carotid atherosclerosis in 223 patients with coronary artery disease. Methods: Coronary angiography, a comprehensive clinical examination, and intima-media thickness measurement by B-mode ultrasound of the carotid arteries (common, internal and bifurcation), were performed at the study start and study end. An expert panel visually evaluated the global change of carotid atherosclerosis on a semiquantitative scale. A second outcome measure was the change of overall mean maximum intima-media thickness. Results: One hundred and seventy-one patients completed the study. In the global change score, 38% of the patients in the fish oil group and 35% in the placebo group showed progression. Global change was not different between intervention groups. Mean maximum intima-media thickness increased by 0.07±0.13 mm and 0.05±0.11 mm in the fish oil and placebo group, respectively (mean±S.D., P=0.24). No correlation was found between the change in carotid and coronary arteries. Conclusions: In this group of selected patients with documented coronary artery disease -3 PUFA given for 2 years did not demonstrate an effect on slowing progression of atherosclerosis in carotid arteries as measured by ultrasound.
KEYWORDS Arteries; Atherosclerosis; Cerebrovascular disorders; Lipid metabolism; Ultrasound
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. S. Harris, D. Mozaffarian, M. Lefevre, C. D. Toner, J. Colombo, S. C. Cunnane, J. M. Holden, D. M. Klurfeld, M. C. Morris, and J. Whelan Towards Establishing Dietary Reference Intakes for Eicosapentaenoic and Docosahexaenoic Acids J. Nutr., April 1, 2009; 139(4): 804S - 819S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. He, K. Liu, M. L Daviglus, E. Mayer-Davis, N. S. Jenny, R. Jiang, P. Ouyang, L. M Steffen, D. Siscovick, C. Wu, et al. Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1111 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mozaffarian Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1991S - 1996S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jew, C. A. Vanstone, J.-M. Antoine, and P. J. H. Jones Generic and Product-Specific Health Claim Processes for Functional Foods across Global Jurisdictions J. Nutr., June 1, 2008; 138(6): 1228S - 1236S. [Abstract] [Full Text] [PDF]
|
|